Dr. André Dallmann is a Scientist for Systems Pharmacology and Science Fellow in the department of Pharmacometrics/Modeling & Simulation at Bayer, Germany. He earned a bachelor’s degree in Biology, a master’s degree in Pharmaceutical Sciences and completed his PhD with a focus on physiologically based pharmacokinetic (PBPK) modelling at the University of Münster, Germany, in 2017. Thereafter, he worked as a postdoctoral researcher at the Pediatric Pharmacology & Pharmacometrics Research Center at the University Children’s Hospital Basel in Switzerland before joining Bayer in 2018.

In his current role as Scientist for Systems Pharmacology at Bayer, Dr. Dallmann develops and applies mechanistic models throughout the clinical development phase to quantitatively characterize drug pharmacokinetics, e.g., with respect to the biopharmaceutical behaviour and drug-drug-interaction risk.

Dr. Dallmann has co-authored more than 35 peer-reviewed articles and book chapters together with various scientists across academia, industry, and regulatory agencies.